|
1
|
Kao ST, Lin CS, Hsieh CC, Hsieh WT and Lin
JG: Effects of Xiao-Qing-Long-Tang (XQLT) on bronchoconstriction
and airway eosinophil infiltration in ovalbumin-sensitized guinea
pigs: In vivo and in vitro studies. Allergy. 56:1164–1171. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ko E, Rho S, Cho C, Choi H, Ko S, Lee Y,
Hong MC, Shin MK, Jung SG and Bae H: So-Cheong-Ryong-Tang,
traditional Korean medicine, suppresses Th2 lineage development.
Biol Pharm Bull. 27:739–743. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ko E, Rho S, Lee E, Seo Y, Cho C, Lee Y,
Min BI, Shin MK, Hong MC and Bae H: Traditional Korean medicine
(SCRT) modulate Th1/Th2 specific cytokine production in mice
CD4+ T cell. J Ethnopharmacol. 92:121–128. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nakao M, Muramoto Y, Hisadome M, Yamano N,
Shoji M, Fukushima Y, Saruwatari J and Nakagawa K: The effect of
Shoseiryuto, a traditional Japanese medicine, on cytochrome P450s,
N-acetyltransferase 2 and xanthine oxidase, in extensive or
intermediate metabolizers of CYP2D6. Eur J Clin Pharmacol.
63:345–353. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lawrence T, Willoughby DA and Gilroy DW:
Anti-inflammatory lipid mediators and insights into the resolution
of inflammation. Nat Rev Immunol. 2:787–795. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guzik TJ, Korbut R and Adamek-Guzik T:
Nitric oxide and superoxide in inflammation and immune regulation.
J Physiol Pharmacol. 54:469–487. 2003.
|
|
7
|
Nathan C: Nitric oxide as a secretory
product of mammalian cells. FASEB J. 6:3051–3064. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
MacMicking J, Xie QW and Nathan C: Nitric
oxide and macrophage function. Annu Rev Immunol. 15:323–350. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nagy G, Clark JM, Buzás EI, Gorman CL and
Cope AP: Nitric oxide, chronic inflammation and autoimmunity.
Immunol Lett. 111:1–5. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Botting RM: Cyclooxygenase: Past, present
and future. A tribute to John R. Vane (1927–2004). J Therm Biol.
31:208–219. 2006. View Article : Google Scholar
|
|
11
|
Blobaum AL and Marnett LJ: Structural and
functional basis of cyclooxygenase inhibition. J Med Chem.
50:1425–1441. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Delgado AV, McManus AT and Chambers JP:
Production of tumor necrosis factor-alpha, interleukin 1-beta,
interleukin 2, and interleukin 6 by rat leukocyte subpopulations
after exposure to substance P. Neuropeptides. 37:355–361. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yoshimura A: Signal transduction of
inflammatory cytokines and tumor development. Cancer Sci.
97:439–447. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Beutler B and Cerami A: The biology of
cachectin/TNF-α primary mediator of the host response. Annu Rev
Immunol. 7:625–655. 1989. View Article : Google Scholar
|
|
15
|
Ghosh S and Ksarin M: Missing pieces in
the NF-kappaB puzzle. Cell. 109(Suppl): S81–S96. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chan ED and Riches DW: IFN-gamma + LPS
induction of iNOS is modulated by ERK, JNK/SAPK, and p38 (mapk) in
a mouse macrophage cell line. Am J Physiol Cell Physiol.
280:C441–C450. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nagai T, Arai Y, Emori M, Nunome SY, Yabe
T, Takeda T and Yamada H: Anti-allergic activity of a Kampo
(Japanese herbal) medicine 'Sho-seiryu-to (Xiao-Qing-Long-Tang)' on
airway inflammation in a mouse model. Int Immunopharmacol.
4:1353–1365. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang SD, Lin LJ, Chen CL, Lee SC, Lin CC,
Wang JY and Kao ST: Xiao-Qing-Long-Tang attenuates allergic airway
inflammation and remodeling in repetitive Dermatogoides
pteronyssinus challenged chronic asthmatic mice model. J
Ethnopharmacol. 142:531–538. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kao ST, Wang SD, Wang JY, Yu CK and Lei
HY: The Effect of herbal medicine, xiao-qing-long-tang (XQLT), on
allergen-induced bronchial inflammation in mite-sensitized mice.
Allergy. 55:1127–1130. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim YW, Zhao RJ, Park SJ, Lee JR, Cho IJ,
Yang CH, Kim SG and Kim SC: Anti-inflammatory effects of
liquiritigenin as a consequence of the inhibition of
NF-kappaB-dependent iNOS and pro-inflammatory cytokines production.
Br J Pharmacol. 154:165–173. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee CW, Park SM, Kim YS, Jegal KH, Lee JR,
Cho IJ, Ku SK, Lee JY, Ahn YT, Son Y, et al: Biomolecular evidence
of anti-inflammatory effects by Clematis mandshurica Ruprecht root
extract in rodent cells. J Ethnopharmacol. 155:1141–1155. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee CW, Park SM, Zhao R, Lee C, Chun W,
Son Y, Kim SH, Jung JY, Jegal KH, Cho IJ, et al: Hederagenin, a
major component of Clematis mandshurica Ruprecht root, attenuates
inflammatory responses in RAW 264.7 cells and in mice. Int
Immunopharmacol. 29:528–537. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim SY, Park SM, Hwangbo M, Lee JR, Byun
SH, Ku SK, Cho IJ, Kim SC, Jee SY and Park SJ:
Cheongsangbangpung-tang ameliorated the acute inflammatory response
via the inhibition of NF-κB activation and MAPK phosphorylation.
BMC Complement Altern Med. 17:462017. View Article : Google Scholar
|
|
24
|
Borthakur A, Bhattacharyya S, Dudeja PK
and Tobacman JK: Carrageenan induces interleukin-8 production
through distinct Bcl10 pathway in normal human colonic epithelial
cells. Am J Physiol Gastrointest Liver Physiol. 292:G829–G838.
2007. View Article : Google Scholar
|
|
25
|
Szabó C: Alterations in nitric oxide
production in various forms of circulatory shock. New Horiz.
3:2–32. 1995.PubMed/NCBI
|
|
26
|
Southan GJ and Szabó C: Selective
pharmacological inhibition of distinct nitric oxide synthase
isoforms. Biochem Pharmacol. 51:383–394. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gröesch S, Maier TJ, Schiffmann S and
Geisslinger G: Cyclooxygenase-2 (COX-2)-independent
anticarcinogenic effects of selective COX-2 inhibitors. J Natl
Cancer Inst. 98:736–747. 2006. View Article : Google Scholar
|
|
28
|
Aggarwal BB: Nuclear factor-kappaB: The
enemy within. Cancer Cell. 6:203–208. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Surh YJ, Chun KS, Cha HH, Han SS, Keum YS,
Park KK and Lee SS: Molecular mechanisms underlying chemopreventive
activities of anti-inflammatory phytochemicals: Down-regulation of
COX-2 and iNOS through suppression of NF-kappa B activation. Mutat
Res. 480–481:243–268. 2001. View Article : Google Scholar
|
|
30
|
Lappas M, Permezel M, Georgiou HM and Rice
GE: Nuclear factor kappa B regulation of pro-inflammatory cytokines
in human gestational tissues in vitro. Biol Reprod. 67:668–673.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guha M and Mackman N: LPS induction of
gene expression in human monocytes. Cell Signal. 13:85–94. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xiao ZY, Zhou WX, Zhang YX, Cheng JP, He
JF, Yang RF and Yun LH: Inhibitory effect of linomide on
lipopolysaccharide-induced proinflammatory cytokine tumor necrosis
factor-alpha production in RAW264.7 macrophages through suppression
of NF-kappaB, p38, and JNK activation. Immunol Lett. 114:81–85.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Choi MS, Lee SH, Cho HS, Kim Y, Yun YP,
Jung HY, Jung JK, Lee BC, Pyo HB and Hong JT: Inhibitory effect of
obovatol on nitric oxide production and activation of NF-kappaB/MAP
kinases in lipopolysaccharide-treated RAW 264.7 cells. Eur J
Pharmacol. 556:181–189. 2007. View Article : Google Scholar
|
|
34
|
Mazzari S, Canella R, Petrelli L,
Marcolongo G and Leon A: N-(2-hydroxyethyl)hexadecanamide is orally
active in reducing edema formation and inflammatory hyperalgesia by
down-modulating mast cell activation. Eur J Pharmacol. 300:227–236.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Antonio MA and Souza Brito AR: Oral
anti-inflammatory and anti-ulcerogenic activities of a
hydroalcoholic extract and partitioned fractions of Turnera
ulmifolia (Turneraceae). J Ethnopharmacol. 61:215–228. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Handy RL and Moore PK: A comparison of the
effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hind paw
oedema and NOS activity. Br J Pharmacol. 123:1119–1126. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gupta M, Mazumder UK, Gomathi P and Selvan
VT: Antiinflammatory evaluation of leaves of Plumeria acuminate.
BMC Complement Altern Med. 6:362006. View Article : Google Scholar
|
|
38
|
Holt S, Comelli F, Costa B and Fowler CJ:
Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced
hind paw inflammation in pentobarbital-treated mice: Comparison
with indomethacin and possible involvement of cannabinoid
receptors. Br J Pharmacol. 146:467–476. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu J, Zhang W, Zhou L, Wang X and Lian Q:
Anti-inflammatory effect and mechanism of osthole in rats. Zhong
Yao Cai. 28:1002–1006. 2005.
|
|
40
|
Beloeil H, Ababneh Z, Chung R, Zurakowski
D, Mulkern RV and Berde CB: Effects of bupivacaine and tetrodotoxin
on carrageenan-induced hind paw inflammation in rats (Part 1):
Hyperalgesia, edema, and systemic cytokines. Anesthesiol.
105:128–138. 2006. View Article : Google Scholar
|
|
41
|
Lee JH, Choi YH and Choi BT: The
anti-inflammatory effects of 2 Hz electroacupuncture with different
intensities on acute carrageenan-induced inflammation in the rat
paw. Int J Mol Med. 16:99–102. 2005.PubMed/NCBI
|
|
42
|
Rao CV, Verma AR, Gupta PK and Vijayakumar
M: Anti-inflammatory and anti-nociceptive activities of Fumaria
indica whole plant extract in experimental animals. Acta Pharm.
57:491–498. 2007. View Article : Google Scholar
|
|
43
|
Holgate ST: The role of mast cells and
basophils in inflammation. Clin Exp Allergy. 30(Suppl 1): S28–S32.
2000. View Article : Google Scholar
|
|
44
|
Crimi E, Chiaramondia M, Milanese M, Rossi
GA and Brusasco V: Increased numbers of mast cells in bronchial
mucosa after the late-phase asthmatic response to allergen. Am Rev
Respir Dis. 144:1282–1286. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gauvreau GM, Lee JM, Watson RM, Irani AM,
Schwartz LB and O'Byrne PM: Increased numbers of both airway
basophils and mast cells in sputum after allergen inhalation
challenge of atopic asthmatics. Am J Respir Crit Care Med.
161:1473–1478. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Mitchell EB, Crow J, Williams G and
Platts-Mills TA: Increase in skin mast cells following chronic
house dust mite exposure. Br J Dermatol. 114:65–73. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chanez P, Lacoste JY, Guillot B, Giron J,
Barnéon G, Enander I, Godard P, Michel FB and Bousquet J: Mast
cells' contribution to the fibrosing alveolitis of the scleroderma
lung. Am Rev Respir Dis. 147:1497–1502. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Armbrust T, Batusic D, Ringe B and
Ramadori G: Mast cells distribution in human liver disease and
experimental rat liver fibrosis. Indications for mast cell
participation in development of liver fibrosis. J Hepatol.
26:1042–1054. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Weischer CH: Experimental studies on the
possibility of influencing mast cells in experimental
carrageenin-induced rat paw edema: Histological study on the
effects of some non-steroidal anti-inflammatory agents (author's
transl). Arzneimittelforschung. 26:1867–1870. 1976.In German.
|
|
50
|
Sin YM, Sedgwick AD, Chea EP and
Willoughby DA: Mast cells in newly formed lining tissue during
acute inflammation: A six day air pouch model in the mouse. Ann
Rheum Dis. 45:873–877. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Mehendale SR, Bauer BA and Yuan CS:
Ephedra-containing dietary supplements in the US versus ephedra as
a Chinese medicine. Am J Chin Med. 32:1–10. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wu Z, Kong X, Zhang T, Ye J, Fang Z and
Yang X: Pseudo-ephedrine/ephedrine shows potent anti-inflammatory
activity against TNF-α-mediated acute liver failure induced by
lipopolysaccharide/D-galactosamine. Eur J Pharmacol. 724:112–121.
2014. View Article : Google Scholar
|
|
53
|
Kasahara Y, Hikino H, Tsurufuji S,
Watanabe M and Ohuchi K: Anti-inflammatory actions of ephedrines in
acute inflammations. Planta Med. 325–331. 1985. View Article : Google Scholar
|
|
54
|
Liu HQ, Zhang WY, Luo XT, Ye Y and Zhu XZ:
Paeoniflorin attenuates neuroinflammation and dopaminergic
neurodegeneration in the MPTP model of Parkinson's disease by
activation of adenosine A1 receptor. Br J Pharmacol. 148:314–325.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Liao JC, Deng JS, Chiu CS, Hou WC, Huang
SS, Shie PH and Huang GJ: Anti-inflammatory activities of
Cinnamomum cassia constituents in vitro and in vivo. Evid Based
Complement Alternat Med. 2012:4293202012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Liu L, Hudgins WR, Shack S, Yin MQ and
Samid D: Cinnamic acid: A natural product with potential use in
cancer intervention. Int J Cancer. 62:345–350. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Hadjipavlou-Litina D and Pontiki E:
Aryl-acetic and cinnamic acids as lipoxygenase inhibitors with
antioxidant, anti-inflammatory, and anticancer activity. Methods
Mol Biol. 1208:361–377. 2015. View Article : Google Scholar
|
|
58
|
Schröfelbauer B, Raffetseder J, Hauner M,
Wolkerstorfer A, Ernst W and Szolar OH: Glycyrrhizin, the main
active compound in liquorice, attenuates pro-inflammatory responses
by interfering with membrane-dependent receptor signaling. Biochem
J. 421:473–482. 2009. View Article : Google Scholar
|
|
59
|
Takei H, Baba Y, Hisatsune A, Katsuki H,
Miyata T, Yokomizo K and Isohama Y: Glycyrrhizin inhibits
interleukin-8 production and nuclear factor-kappa B activity in
lung epithelial cells, but not through glucocorticoid receptors. J
Pharmacol Sci. 106:460–468. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Menegazzi M, Di Paola R, Mazzon E,
Genovese T, Crisafulli C, Dal Bosco M, Zou Z and Suzuki H:
Glycyrrhizin attenuates the development of carrageenan-induced lung
injury in mice. Pharmacol Res. 58:22–31. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Teraoka R, Shimada T and Aburada M: The
molecular mechanisms of the hepatoprotective effect of gomisin A
against oxidative stress and inflammatory response in rats with
carbon tetrachloride-induced acute liver injury. Biol Pharm Bull.
35:171–177. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Wang X, Hu D, Zhang L, Lian G, Zhao S,
Wang C, Yin J, Wu C and Yang J: Gomisin A inhibits
lipopolysaccharide-induced inflammatory responses in N9 microglia
via blocking the NF-κB/MAPKs pathway. Food Chem Toxicol.
63:119–127. 2014. View Article : Google Scholar
|
